Lansoprazole Stada
Instructions for use:
- 1. Release form and composition
- 2. Indications for use
- 3. Contraindications
- 4. Method of application and dosage
- 5. Side effects
- 6. Special instructions
- 7. Drug interactions
- 8. Analogs
- 9. Terms and conditions of storage
- 10. Terms of dispensing from pharmacies
Lansoprazole Stada is an antiulcer drug.
Release form and composition
Dosage form - capsules No. 1: hard, gelatinous, red; contents - pellets of spherical shape, enteric coated white (10 pcs. in a blister or cell-free package, in a cardboard box 1, 2 or 3 packages).
The active ingredient of Lansoprazole Stad is lansoprazole: in 1 capsule - 30 mg.
Auxiliary components: potato starch, sucrose, carmellose, lactose, povidone (K-30), magnesium carbonate, hypromellose, sodium hydroxide, polysorbate, diethyl phthalate, methacrylic acid, ethanol, mannitol, propylene glycol.
Capsule composition: gelatin, karmazin, water.
Indications for use
Lansoprazole Stada is used to treat the following diseases:
- Peptic ulcer and 12 duodenal ulcer;
- Stress ulcers;
- Gastrinoma (Zollinger-Ellison syndrome);
- Erosive and ulcerative lesions of the stomach and duodenal ulcer, developed as a result of the previous use of non-steroidal anti-inflammatory drugs (NSAIDs);
- Erosive and ulcerative lesions of the stomach and duodenum, associated with the bacterium Helicobacter pylori (complex therapy);
- Erosive and ulcerative esophagitis and reflux esophagitis.
Contraindications
Absolute:
- Malignant neoplasms in the gastrointestinal tract;
- Age under 18;
- First trimester of pregnancy;
- Lactation;
- Hypersensitivity to the drug.
Relative (special care must be taken due to the risk of complications):
- Renal / hepatic impairment;
- Elderly age;
- Second and third trimesters of pregnancy.
Method of administration and dosage
Lansoprazole Stada is taken orally by swallowing the capsules whole.
Recommended doses depending on indications:
- Exacerbation of duodenal ulcer: 30 mg per day, in cases of increased resistance - 60 mg / day. The course of treatment is 2-4 weeks;
- Exacerbation of gastric ulcer: 30-60 mg / day (at the discretion of the doctor) for 4-8 weeks;
- Erosive and ulcerative lesions of the gastrointestinal tract due to the use of NSAIDs: 30 mg / day for 4-8 weeks;
- Eradication of Helicobacter pylori (in combination with antibacterial drugs): 30 mg 2 times a day for 10-14 days;
- Anti-relapse therapy of reflux esophagitis: 30 mg per day, long-term treatment (up to 6 months);
- Treatment of peptic ulcer disease, aimed at preventing relapse: 30 mg per day;
- Zollinger-Ellison syndrome: the dose is selected individually, treatment is carried out until a basal secretion level of less than 10 mmol / hour is reached.
Side effects
Possible side effects associated with the use of the drug:
- Digestive system: change in appetite (decrease or increase), abdominal pain, nausea; rarely, constipation or diarrhea; in individual cases - increased activity of liver enzymes and the level of bilirubin in the blood, candidiasis of the gastrointestinal tract, ulcerative colitis;
- Central Nervous System: headache; rarely - drowsiness, dizziness, malaise, anxiety, depression;
- Respiratory system: rarely - rhinitis, pharyngitis, cough, flu-like syndrome, upper respiratory tract infection;
- Hematopoietic system: rarely - thrombocytopenia (including with hemorrhagic manifestations), anemia;
- Allergic reactions: skin rash; in individual cases - erythema multiforme, photosensitivity;
- Others: rarely - alopecia, myalgia.
special instructions
Before prescribing Lansoprazole Stad, the presence of a malignant process in the upper gastrointestinal tract should be excluded, since the drug can mask its symptoms, thereby complicating timely diagnosis.
Drug interactions
When interacting with other medicinal products, lansoprazole:
- Slows down the excretion of drugs that are metabolized by microsomal oxidation in the liver, including indirect anticoagulants, phenytoin and diazepam;
- Reduces the theophylline clearance by 10%;
- Changes the pH-dependent absorption of drugs from the groups of weak acids (slows down) and bases (speeds up).
Antacids slow down and reduce the absorption of lansoprazole (if it is necessary to use such a combination, they are taken no later than 1 hour before taking Lansoprazole Stad or after 1-2 hours).
Sucralfate reduces the bioavailability of lansoprazole by 30%, for this reason, 30-minute intervals must be observed between doses of these drugs.
Analogs
Lansoprazole Stada analogs are: Lanzaptol, Lancid, Epikur, Akrilanz, Helikol, Lanzabel, Lanzap, Lansofed, Loenzar-Sanovel.
Terms and conditions of storage
Store at temperatures up to 25 ° C in a dry and dark place out of reach of children.
Shelf life is 2 years.
Terms of dispensing from pharmacies
Dispensed by prescription.
Information about the drug is generalized, provided for informational purposes only and does not replace the official instructions. Self-medication is hazardous to health!
